Diabetes Mellitus
- Diabetes-Related Macular Edema
- CDC Managing Blood Sugar
- AFP Publications: Type 2 Diabetes
- Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison
- The Links Between Sleep Duration, Obesity and Type 2 Diabetes Mellitus
- Obesity Management as a Primary Treatment Goal for Type 2 Diabetes: Time to Reframe the Conversation
- Standards of Medical Care in Diabetes—2022
- Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
- Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
- New Decade, New FDA Guidance for Diabetes Drug Development
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
- 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
- AACE Diabetes Resource Center
- Diabetic Retinopathy: A Position Statement by the ADA
- Accurate Insulin Decisions – For Doctors
- Family Practice Management Toolbox: Diabetes
- Diabetes and You: All Medicines Matter!
- Mealtime Insulin Management
- Advanced Insulin Management: Using Insulin-to-Carb Ratios and Correction Factors
- 4 Steps to Manage Your Diabetes for Life
- Living with Diabetes
Acromegaly
- Acromegaly Patient Information
- Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly—2011 Update: Executive Summary
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- A Comprehensive Review of Four Clinical Practice Guidelines of Acromegaly
- Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly
- Results From the Phase 3, Randomized, Double-Blind, Placebo-Controlled OPTIMAL Study of Oral Octreotide Capsules in Adult Patients with Acromegaly
Osteoporosis
- Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society
- Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis
- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
- Overview of the management of osteoporosis in postmenopausal women
- Clinician’s Guide to the Prevention and Treatment of Osteoporosi
- New Insights into Treatment of Osteoporosis in Postmenopausal Women
- NIH Handout on Health: Osteoporosis – Patient Handout